LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in LENZ Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- −2 vs. Q3 2021
- Shares held
- 34.7M
- −1.24M (−3.4%) vs. Q3 2021
- Total value
- $431.7M
- −$155.7M (−26.5%) vs. Q3 2021
- New holders
- 9
- 25 more added
- Sold out
- 11
- 11 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 169 | $2.00K | 0.00% | +169 | New |
| Federation des caisses Desjardins du Quebec | 200 | $2.49K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 270 | $3.36K | 0.00% | +250+1,250.0% | Added |
| Ameritas Investment Partners, Inc. | 1,246 | $15.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,320 | $16.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,519 | $19.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,167 | $39.0K | 0.00% | +1,251+65.3% | Added |
| STRS Ohio | 3,700 | $45.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 5,802 | $72.0K | 0.00% | +3,915+207.5% | Added |
| New York State Common Retirement Fund | 5,840 | $73.0K | 0.00% | +140+2.5% | Added |
| Tower Research Capital LLC (TRC) | 5,961 | $74.0K | 0.00% | +5,280+775.3% | Added |
| Allspring Global Investments Holdings, LLC | 6,714 | $83.0K | 0.00% | +6,714 | New |
| UBS Group AG | 7,881 | $98.0K | 0.00% | +5,372+214.1% | Added |
| American International Group, Inc. | 8,636 | $107.0K | 0.00% | −257−2.9% | Reduced |
| California State Teachers Retirement System | 8,802 | $109.0K | 0.00% | +22+0.3% | Added |
| Deutsche Bank AG | 9,859 | $123.0K | 0.00% | +512+5.5% | Added |
| JPMorgan Chase & Co | 11,344 | $141.0K | 0.00% | +5,120+82.3% | Added |
| Rhumbline Advisers | 11,686 | $145.0K | 0.00% | −60−0.5% | Reduced |
| ProShare Advisors LLC | 11,730 | $147.0K | 0.00% | +11,730 | New |
| Wells Fargo & Company | 12,912 | $160.0K | 0.00% | +9,960+337.4% | Added |
| Cubist Systematic Strategies, LLC | 13,407 | $167.0K | 0.00% | +4,730+54.5% | Added |
| Cetera Advisor Networks LLC | 14,400 | $179.0K | 0.00% | +3,000+26.3% | Added |
| Virtus ETF Advisers LLC | 15,855 | $197.0K | 0.07% | +15,855 | New |
| Nuveen Asset Management, LLC | 23,547 | $240.0K | 0.00% | −10,764−31.4% | Reduced |
| Goldman Sachs Group Inc | 19,891 | $247.0K | 0.00% | −54,218−73.2% | Reduced |
| Jefferies Group LLC | 30,074 | $373.8K | 0.01% | +30,074 | New |
| Jane Street Group, LLC | 41,860 | $520.0K | 0.00% | +41,860 | New |
| Charles Schwab Investment Management Inc | 42,612 | $530.0K | 0.00% | +2,815+7.1% | Added |
| Bank of New York Mellon Corp | 45,782 | $569.0K | 0.00% | +6,388+16.2% | Added |
| Bank of America Corp | 66,290 | $824.0K | 0.00% | +35,777+117.3% | Added |
| Ergoteles LLC | 72,155 | $897.0K | 0.03% | +72,155 | New |
| Millennium Management LLC | 126,708 | $1.57M | 0.00% | −414,439−76.6% | Reduced |
| Northern Trust Corp | 165,415 | $2.06M | 0.00% | +22,216+15.5% | Added |
| Cormorant Asset Management, LP | 203,153 | $2.52M | 0.15% | 00.0% | Unchanged |
| State Street Corp | 256,482 | $3.19M | 0.00% | +59,841+30.4% | Added |
| UBS Asset Management Americas Inc | 256,726 | $3.19M | 0.00% | −185,978−42.0% | Reduced |
| Geode Capital Management, LLC | 269,177 | $3.35M | 0.00% | +11,801+4.6% | Added |
| Woodline Partners LP | 300,031 | $3.73M | 0.05% | 00.0% | Unchanged |
| Logos Global Management LP | 406,308 | $5.05M | 0.52% | −800,000−66.3% | Reduced |
| OUP Management Co., LLC | 406,308 | $5.05M | 2.28% | +406,308 | New |
| Norges Bank | 554,167 | $6.89M | 0.00% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 663,194 | $8.24M | 0.98% | +131,925+24.8% | Added |
| EcoR1 Capital, LLC | 688,900 | $8.56M | 0.27% | +688,900 | New |
| Morgan Stanley | 698,380 | $8.68M | 0.00% | +284,615+68.8% | Added |
| Artal Group S.A. | 700,000 | $8.70M | 0.26% | 00.0% | Unchanged |
| Vanguard Group Inc | 700,374 | $8.71M | 0.00% | +3,943+0.6% | Added |
| Board of Trustees of The Leland Stanford Junior University | 703,071 | $8.74M | 0.55% | 00.0% | Unchanged |
| Avidity Partners Management LP | 710,000 | $8.82M | 0.19% | −38,995−5.2% | Reduced |
| Perceptive Advisors LLC | 850,093 | $10.6M | 0.16% | −25,000−2.9% | Reduced |
| Federated Hermes, Inc. | 1,056,308 | $13.1M | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 1,212,268 | $15.1M | 0.00% | +262,354+27.6% | Added |
| Citadel Advisors LLC | 1,245,279 | $15.5M | 0.02% | −24,894−2.0% | Reduced |
| OrbiMed Advisors LLC | 1,565,812 | $19.5M | 0.25% | +115,908+8.0% | Added |
| VR Adviser, LLC | 1,612,617 | $20.0M | 2.74% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 2,078,910 | $25.8M | 0.60% | +2,200+0.1% | Added |
| Ra Capital Management, L.P. | 2,698,369 | $33.5M | 0.59% | 00.0% | Unchanged |
| FMR LLC | 6,247,690 | $77.7M | 0.01% | −1,9160.0% | Reduced |
| Samsara BioCapital, LLC | 7,851,933 | $97.6M | 19.44% | +420,310+5.7% | Added |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −958,079−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −906,308−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −296,375−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −60,905−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −53,472−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −7,247−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −6,861−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −5,191−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |